Open AccessAbstract 1106: Co-administration of the iRGD tumor-penetrating peptide improves the tumor immunostimulatory effects of low-dose IL-2
Author(s) -
Harri A. Järveläinen,
Gregory P. Botta,
Tatiana Hurtado de Mendoza,
Erkki Ruoslahti
Publication year - 2019
Publication title -
tumor biology
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1423-0380
pISSN - 1010-4283
DOI - 10.1158/1538-7445.sabcs18-1106
Subject(s) - peptide , cancer research , medicine , pharmacology , chemistry , biochemistry